A popular drug used for diabetes and weight loss may also help protect the brain. That’s the key message from a new study ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...

In this cohort study of adults prescribed semaglutide, initiation was associated with reductions in weight and cardiovascular risk ...

In this cohort study of adults prescribed semaglutide, initiation was associated with reductions in weight and cardiovascular risk factors but increases in health care expenditures, excluding ...

The risk for major adverse cardiovascular events decreased with tirzepatide vs. liraglutide and semaglutide in patients with ...

NAION is the second most frequent cause of vision loss due to optic nerve damage, with advanced age and long-standing type 2 ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some users feeling seriously unwell and many in hospital. After scouring ...

Those taking semaglutide often have other health conditions that can raise the risk of NAION. There’s also a theory that GLP-1 drugs may activate your sympathetic nervous system (your body’s ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.